Zühlke vs Sagentia Innovation: full comparison for 2026
Quick verdict
Zühlke (4.4/5) edges ahead of Sagentia Innovation (4.1/5) overall. Zühlke is the better choice for european medtech firms modernizing device software. Sagentia Innovation is the stronger option for surgical robotics and combination products. The right choice depends on your project size, budget, and required tech stack.
Zühlke vs Sagentia Innovation: head-to-head summary
| Criterion | Zühlke | Sagentia Innovation |
|---|---|---|
| Founded | 1968 | 1986 |
| HQ | Schlieren, Switzerland | Harston, Cambridge, UK |
| Team size | 1,500–2,000 | 650+ (Science Group) |
| Rating | 4.4 / 5 | 4.1 / 5 |
| Primary differentiator | A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program | Medical development backed by a listed science group that also runs a regulatory consultancy |
| Pricing model | Time and materials, fixed project | Time and materials, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Embedded Linux, Cloud (AWS/Azure) | Embedded C/C++, Robotics, Mechanical simulation |
| Industries served | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services | Surgical & robotics, Drug delivery, Diagnostics & lab devices |
Zühlke vs Sagentia Innovation: overview
Zühlke
Partner-owned since its 1968 founding in Switzerland, Zühlke is headquartered in Schlieren near Zurich, with teams in Germany, Austria, the UK, Serbia and Asia. Its headcount is somewhere between 1,500 and 2,000 depending on the source. In healthcare it covers regulated device and systems engineering, connected-device software and the cloud and analytics platforms around devices, and it states more than 50 years of medtech experience (per company website; independently unverifiable).
Sagentia Innovation
Sagentia Innovation is owned by Science Group plc, which is listed on the London Stock Exchange's AIM market. Its roots go back to 1986; the current business was formed in 2021 from Sagentia, OTM Consulting and Oakland Innovation. It is based at Harston Mill near Cambridge, with R&D facilities in Cambridge and Epsom, and its medical work covers devices, combination products and surgical robotics. Science Group employs more than 650 people across all its businesses.
Services and capabilities: Zühlke vs Sagentia Innovation
| Capability | Zühlke | Sagentia Innovation |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✓ | ✗ |
| Connected devices & IoT | ✓ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✗ |
Tech stack comparison: Zühlke vs Sagentia Innovation
| Framework / platform | Zühlke | Sagentia Innovation |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | ✓ | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | ✓ | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | ✓ | N/A |
Pricing comparison: Zühlke vs Sagentia Innovation
| Criterion | Zühlke | Sagentia Innovation |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Dedicated team, Fixed project, Time & materials | Consulting, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Zühlke vs Sagentia Innovation
| Dimension | Zühlke | Sagentia Innovation |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices | Surgical & robotics, Drug delivery, Diagnostics & lab devices |
| Best use cases | Rebuilding the embedded and cloud software of an established diagnostics platform, EU MDR remediation of legacy device software | Surgical robot subsystem development, Drug-device combination product engineering |
| Typical project type | Consulting | Consulting |
Zühlke vs Sagentia Innovation: pros and cons
| Zühlke | |
|---|---|
| + | Partner ownership keeps the firm independent of a large holding group |
| + | Large enough to staff hardware, embedded, cloud and data roles at the same time |
| + | Delivery centres in Serbia and Asia give some cost flexibility compared with all-Swiss teams |
| + | Experience with EU MDR environments in German-speaking markets |
| - | Much of the firm works outside healthcare, so check that the proposed team is from the medtech practice |
| - | Swiss and German rates are high for the onshore part of a team |
| - | Industrial design and manufacturing are not core offerings |
| Sagentia Innovation | |
|---|---|
| + | Active surgical robotics software and hardware hiring shows current work in that area |
| + | Sister business TSG Consulting has a medical device regulatory team |
| + | Large owned R&D facilities in Cambridge and Epsom |
| + | About 30 years of medical device projects |
| - | Part of a listed group, so commercial priorities answer to public shareholders |
| - | Recent 2021 merger means the brand and teams are relatively new |
| - | Science Group headcount covers many businesses, so the medtech team size is unclear |
Who should choose Zühlke?
A typical fit: rebuilding the embedded and cloud software of an established diagnostics platform.
A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services.
Who should choose Sagentia Innovation?
A typical fit: surgical robot subsystem development.
Medical development backed by a listed science group that also runs a regulatory consultancy. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Diagnostics & lab devices.
Decision matrix: Zühlke vs Sagentia Innovation
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Zühlke |
| You need a large dedicated team for an ongoing programme | Zühlke |
| Your budget is at the lower end | Compare: Zühlke (Not disclosed) vs Sagentia Innovation (Not disclosed) |
| You need specialist depth in a specific vertical | Zühlke |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Zühlke vs Sagentia Innovation
| Use case | Zühlke fit | Sagentia Innovation fit | Winner |
|---|---|---|---|
| Rebuilding the embedded and cloud software of an established diagnostics platform | Strong | Limited | Zühlke |
| EU MDR remediation of legacy device software | Strong | Limited | Zühlke |
| Surgical robot subsystem development | Limited | Strong | Sagentia Innovation |
| Drug-device combination product engineering | Limited | Strong | Sagentia Innovation |
Verdict: Zühlke vs Sagentia Innovation
Zühlke (4.4/5) is the stronger overall choice for most Medical Device Development projects. A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program.
Sagentia Innovation (4.1/5) is worth a look if you need drug-device combination product engineering. If your situation matches that, Sagentia Innovation is a competitive option.
Related comparisons
Zühlke vs Sagentia Innovation FAQ
Is Zühlke better than Sagentia Innovation?
Zühlke (4.4/5) scores higher overall, but "better" depends on your use case. Zühlke's strongest advantage: partner ownership keeps the firm independent of a large holding group. Sagentia Innovation's strongest advantage: active surgical robotics software and hardware hiring shows current work in that area.
How do Zühlke and Sagentia Innovation differ in pricing?
Zühlke uses time and materials, fixed project pricing. Sagentia Innovation uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Zühlke or Sagentia Innovation?
Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Zühlke and Sagentia Innovation?
Zühlke's primary differentiator is: a device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Sagentia Innovation's primary differentiator is: medical development backed by a listed science group that also runs a regulatory consultancy. They also differ in team size (1,500–2,000 vs 650+ (Science Group)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Digital health, Diagnostics & lab devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.